Sex Differences in Outcome After Thrombectomy for Acute Ischemic Stroke are Explained by Confounding Factors.


Journal

Clinical neuroradiology
ISSN: 1869-1447
Titre abrégé: Clin Neuroradiol
Pays: Germany
ID NLM: 101526693

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 10 09 2020
accepted: 21 11 2020
pubmed: 22 12 2020
medline: 15 12 2021
entrez: 21 12 2020
Statut: ppublish

Résumé

The aim of this study was to analyze sex differences in outcome after thrombectomy for acute ischemic stroke in clinical practice in a large prospective multicenter registry. Data of consecutive stroke patients treated with thrombectomy (June 2015-April 2018) derived from an industry-independent registry (German Stroke Registry-Endovascular Treatment) were prospectively analyzed. Multivariable binary logistic regression analyses were applied to determine whether sex is a predictor of functional independence outcome (defined as a modified Rankin scale [mRS] 0-2) 90 days after stroke. In total, 2316 patients were included in the analysis, 1170 (50.5%) were female and 1146 (49.5%) were male. Women were older (median age 78 vs. 72 years; p < 0.001) and more frequently had a prestroke functional impairment defined by mRS >1 (24.8% vs. 14.1%; p < 0.001). In unadjusted analyses, independent outcome at 90 days was less frequent in women (33.2%) than men (40.6%; p < 0.001). Likewise, mortality was higher in women than in men (30.7% vs. 26.4%; p = 0.024). In adjusted regression analyses, however, sex was not associated with outcome. Lower age, a lower baseline National Institutes of Health Stroke Scale score, a higher Alberta Stroke Program Early CT score, prestroke functional independence, successful reperfusion, and concomitant intravenous thrombolysis therapy predicted independent outcome. Women showed a worse functional outcome after thrombectomy for acute ischemic stroke in clinical practice; however, after adjustment for crucial confounders sex was not a predictor of outcome. The difference in outcome thus appears to result from differences in confounding factors such as age and prestroke functional status.

Identifiants

pubmed: 33346850
doi: 10.1007/s00062-020-00983-2
pii: 10.1007/s00062-020-00983-2
pmc: PMC8648700
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1101-1109

Investigateurs

C Gerloff (C)
J Fiehler (J)
G Thomalla (G)
A Alegiani (A)
None Boeckh-Behrens
Silke Wunderlich (S)
Ulrike Ernemann (U)
Sven Poli (S)
Eberhard Siebert (E)
Christian H Nolte (CH)
Sarah Zweynert (S)
Georg Bohner (G)
Alexander Ludolph (A)
Karl-Heinz Henn (KH)
Waltraud Pfeilschifter (W)
Fee Keil (F)
Joachim Röther (J)
Bernd Eckert (B)
Jörg Berrouschot (J)
Albrecht Bormann (A)
László Solymosi (L)
Gabor Petzold (G)
Christoffer Kraemer (C)
Martin Dichgans (M)
Steffen Tiedt (S)
Lars Kellert (L)
Franziska Dorn (F)
Martina Petersen (M)
Florian Stögbauer (F)
Michael Braun (M)
Gerhard F Hamann (GF)
Klaus Gröschel (K)
Timo Uphaus (T)

Informations de copyright

© 2020. The Author(s).

Références

Neuroepidemiology. 2005;24(3):123-8
pubmed: 15637449
Stroke. 2019 Sep;50(9):2413-2419
pubmed: 31412753
Neuroepidemiology. 2012;39(1):57-62
pubmed: 22777655
Ther Adv Neurol Disord. 2017 May;10(5):241-244
pubmed: 28529545
Interv Neurol. 2016 Sep;5(3-4):174-178
pubmed: 27781046
Interv Neurol. 2018 Feb;7(1-2):42-47
pubmed: 29628944
J Neurointerv Surg. 2019 Mar;11(3):221-225
pubmed: 30097482
Stroke. 2019 Sep;50(9):2500-2506
pubmed: 31337298
J Neurointerv Surg. 2019 Nov;11(11):1091-1094
pubmed: 31030188
Cerebrovasc Dis. 2010;30(5):470-5
pubmed: 20733301
Int J Stroke. 2019 Jun;14(4):372-380
pubmed: 30346260
Stroke. 2019 Sep;50(9):2420-2427
pubmed: 31412752
Stroke. 2015 Mar;46(3):860-3
pubmed: 25633999
BMJ. 2018 Mar 9;360:k949
pubmed: 29523557
Curr Cardiol Rep. 2010 Jan;12(1):6-13
pubmed: 20425178
Lancet Neurol. 2008 Oct;7(10):915-26
pubmed: 18722812
JAMA Cardiol. 2017 Jan 1;2(1):108-110
pubmed: 27784042
Neurology. 2018 May 29;90(22):e1945-e1953
pubmed: 29703773
Stroke. 2018 Mar;49(3):e46-e110
pubmed: 29367334
Stroke. 2003 May;34(5):1114-9
pubmed: 12690218
J Neurointerv Surg. 2020 Nov;12(11):1064-1068
pubmed: 32107288

Auteurs

Milani Deb-Chatterji (M)

Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. m.deb-chatterji@uke.de.

Eckhard Schlemm (E)

Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Fabian Flottmann (F)

Department of Interventional Neuroradiology and Diagnostics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Lukas Meyer (L)

Department of Interventional Neuroradiology and Diagnostics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Anna Alegiani (A)

Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Caspar Brekenfeld (C)

Department of Interventional Neuroradiology and Diagnostics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Jens Fiehler (J)

Department of Interventional Neuroradiology and Diagnostics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Christian Gerloff (C)

Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Götz Thomalla (G)

Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH